{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:19:09Z","timestamp":1792876749168,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd015046","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000}}],"reference-count":98,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015046.pub2","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:34:15Z","timestamp":1760556855000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacological and non-pharmacological treatments for impulsive-compulsive behaviors in Parkinson's disease"],"prefix":"10.1002","volume":"2025","author":[{"given":"Elisa","family":"Mantovani","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences; University of Verona; Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Martini","sequence":"additional","affiliation":[{"name":"School of Psychology; University of Keele; Newcastle-under-Lyme UK"},{"name":"Department of Addictions and Mental Health; Azienda Sanitaria Friuli Occidentale; Pordenone Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Purgato","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences; University of Verona; Verona Italy"},{"name":"Cochrane Global Mental Health; Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Tamburin","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences; University of Verona; Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"10.1002\/14651858.CD015046.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11910-016-0647-4","article-title":"Neuropsychiatric issues in Parkinson\u2019s disease","volume":"16(5)","author":"Cooney","year":"2016","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"1","key":"10.1002\/14651858.CD015046.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"89\u2013102","DOI":"10.1016\/S1474-4422(21)00330-6","article-title":"The neuropsychiatry of Parkinson's disease: advances and challenges","volume":"21","author":"Weintraub","year":"2022","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0003|cit3","first-page":"679\u2013717","article-title":"Impulse control and related disorders in Parkinson's disease","volume":"133","author":"Weintraub","year":"2017","journal-title":"International Review of Neurobiology"},{"issue":"11","key":"10.1002\/14651858.CD015046.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"3580\u201391","DOI":"10.1093\/brain\/awz298","article-title":"Lower nucleus accumbens \u03b1-synuclein load and D3 receptor levels in Parkinson's disease with impulsive compulsive behaviours","volume":"142","author":"Barbosa","year":"2019","journal-title":"Brain: A Journal of Neurology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"134313","DOI":"10.1016\/j.neulet.2019.134313","article-title":"Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease","volume":"707","author":"Liu","year":"2019","journal-title":"Neuroscience Letters"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0006|cit6","first-page":"1298\u20131315","article-title":"Risk factors of impulsive-compulsive behaviors in PD patients: a meta-analysis","volume":"269(3)","author":"Cao","year":"2022","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0007|cit7","first-page":"589","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67(5)","author":"Weintraub","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0008|cit8","first-page":"986\u201396","article-title":"Impulse control disorders in Parkinson disease: a multicenter case-control study","volume":"69(6)","author":"Voon","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0009|cit9","first-page":"1106\u201311","article-title":"Clinical-genetic model predicts incident impulse control disorders in Parkinson\u2019s disease","volume":"87(10)","author":"Kraemmer","year":"2016","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD015046.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"238\u201350","DOI":"10.1016\/S1474-4422(17)30004-2","article-title":"Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update","volume":"16","author":"Voon","year":"2017","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1002\/14651858.CD015046.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/jnnp-2017-316576","article-title":"Sleep and REM sleep behaviour disorder in Parkinson's disease with impulse control disorder","volume":"89","author":"Fantini","year":"2018","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1093\/brain\/awaa198","article-title":"Dopamine and reward hypersensitivity in Parkinson\u2019s disease with impulse control disorder","volume":"143(8)","author":"Drew","year":"2020","journal-title":"Brain: A Journal of Neurology"},{"issue":"12","key":"10.1002\/14651858.CD015046.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1178\u201381","DOI":"10.1016\/j.jocn.2007.01.009","article-title":"Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists","volume":"14","author":"Singh","year":"2007","journal-title":"Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2016.02.017","article-title":"The prevalence and clinical characteristics of hypersexuality in patients with Parkinson's disease following dopaminergic therapy: a systematic literature review","volume":"25","author":"Nakum","year":"2016","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0015|cit15","first-page":"183","article-title":"Impulsive and compulsive behaviors in Parkinson's disease: the Norwegian ParkWest study","volume":"7(1)","author":"Erga","year":"2017","journal-title":"Journal of Parkinson's Disease"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0016|cit16","first-page":"e189","article-title":"Longitudinal analysis of impulse control disorders in Parkinson disease","volume":"91(3)","author":"Corvol","year":"2018","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0017|cit17","first-page":"1127\u201336","article-title":"Dynamics of impulsive-compulsive behaviors in early Parkinson's disease: a prospective study","volume":"267(4)","author":"Markovi\u0107","year":"2020","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/mds.22505","article-title":"Impulsive and compulsive behaviors in Parkinson\u2019s disease","volume":"24(11)","author":"Evans","year":"2009","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/gps.2704","article-title":"Carer burden in apathy and impulse control disorders in Parkinson's disease","volume":"27(2)","author":"Leroi","year":"2012","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jocn.2013.02.032","article-title":"Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients","volume":"21(1)","author":"Phu","year":"2014","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/ADM.0000000000000574","article-title":"Pharmacological and psychosocial treatment of adults with gambling disorder: a meta-review","volume":"14(4)","author":"Di Nicola","year":"2020","journal-title":"Journal of Addiction Medicine"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3389\/fnins.2020.00729","article-title":"Non-invasive brain stimulation for gambling disorder: a systematic review","volume":"14","author":"Zucchella","year":"2020","journal-title":"Frontiers in Neuroscience"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0023|cit23","first-page":"402\u20136","article-title":"A systematic review of treatments for impulse control disorders and related behaviours in Parkinson's disease","volume":"225(3)","author":"Tanwani","year":"2015","journal-title":"Psychiatry Research"},{"issue":"12","key":"10.1002\/14651858.CD015046.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1060\u20134","DOI":"10.1136\/jnnp-2017-315985","article-title":"Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases","volume":"88","author":"Warren","year":"2017","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.parkreldis.2017.07.030","article-title":"The rise and fall of impulse control behavior disorders","volume":"46(1)","author":"Cossu","year":"2018","journal-title":"Parkinsonism & Related Disorders"},{"issue":"2","key":"10.1002\/14651858.CD015046.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"180\u201398","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"8","key":"10.1002\/14651858.CD015046.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2174\/1871527319666200720105553","article-title":"Management of impulse control disorders with subthalamic nucleus deep brain stimulation in Parkinson's disease","volume":"19","author":"Amstutz","year":"2020","journal-title":"CNS & Neurological Disorders Drug Targets"},{"issue":"5","key":"10.1002\/14651858.CD015046.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/14737175.2025.2485337","article-title":"Managing impulse control and related behavioral disorders in Parkinson's disease: where we are in 2025?","volume":"25","author":"Rigon","year":"2025","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1007\/s10072-021-05237-8","article-title":"New pharmacological and neuromodulation approaches for impulsive-compulsive behaviors in Parkinson's disease","volume":"42(7)","author":"Grassi","year":"2021","journal-title":"Neurological Sciences"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3389\/fneur.2018.01018","article-title":"Dopaminergic neurotransmission in patients with Parkinson's disease and impulse control disorders: a systematic review and meta-analysis of PET and SPECT studies","volume":"9","author":"Martini","year":"2018","journal-title":"Frontiers in Neurology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"165\u201377","DOI":"10.1016\/j.parkreldis.2020.07.020","article-title":"Incentive-driven decision-making networks in de novo and drug-treated Parkinson's disease patients with impulsive-compulsive behaviors: a systematic review of neuroimaging studies","volume":"78","author":"Martini","year":"2020","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3389\/fneur.2018.00654","article-title":"Impulse control disorder in Parkinson's disease: a meta-analysis of cognitive, affective, and motivational correlates","volume":"9","author":"Martini","year":"2018","journal-title":"Frontiers in Neurology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mds.23501","article-title":"Impulsivity and compulsivity in drug-na\u00efve patients with Parkinson's disease","volume":"26(3)","author":"Antonini","year":"2011","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","article-title":"Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study","volume":"80(2)","author":"Weintraub","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD015046.pub2-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015046","article-title":"Pharmacological and non-pharmacological treatments for impulsive-compulsive behaviors in Parkinson's disease","author":"Mantovani","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0036|cit36","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual 2023"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0037|cit37","first-page":"71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Edition)"},{"issue":"6","key":"10.1002\/14651858.CD015046.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"791\u20138","DOI":"10.1002\/mds.27689","article-title":"Scales to assess impulsive and compulsive behaviors in Parkinson's disease: critique and recommendations","volume":"34","author":"Evans","year":"2019","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0039|cit39","unstructured":"International Parkinson and Movement Disorder Society MDS Recommended Rating Scales www.movementdisorders.org\/MDS\/Education\/Rating-Scales\/MDS-Recommended-Rating-Scales.htm"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0040|cit40","first-page":"1461\u20137","article-title":"Validation of the questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease","volume":"24(10)","author":"Weintraub","year":"2009","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0041|cit41","first-page":"242\u20137","article-title":"Questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease - rating scale","volume":"27(2)","author":"Weintraub","year":"2012","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0042|cit42","first-page":"5","article-title":"Compulsive buying: descriptive characteristics and psychiatric comorbidity","volume":"55(1)","author":"Christenson","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/mdc3.12316","article-title":"Impulse-control scale for the severity rating of impulse-control behaviors in Parkinson's disease: a semistructured clinical assessment tool","volume":"3(5)","author":"Okai","year":"2016","journal-title":"Movement Disorders Clinical Practice"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0044|cit44","first-page":"1184\u20138","article-title":"The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers","volume":"144(9)","author":"Lesieur","year":"1987","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD015046.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","article-title":"Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome","volume":"19","author":"Evans","year":"2004","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1002\/14651858.CD015046.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/mp.2009.95","article-title":"Insights into pathophysiology of punding reveal possible treatment strategies","volume":"15","author":"Fasano","year":"2010","journal-title":"Molecular Psychiatry"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.brat.2003.07.006","article-title":"Measurement of compulsive hoarding: saving inventory-revised","volume":"42(10)","author":"Frost","year":"2004","journal-title":"Behaviour Research and Therapy"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0048|cit48","first-page":"845\u201356","article-title":"Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease","volume":"165(11)","author":"Ardouin","year":"2009","journal-title":"Revue Neurologique"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/mds.21696","article-title":"Assessment of psychiatric complications in Parkinson's disease: the SCOPA-PC","volume":"22(15)","author":"Visser","year":"2007","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0050|cit50","first-page":"2299\u2013308","article-title":"A short scale for evaluation of neuropsychiatric disorders in Parkinson\u2019s disease: first psychometric approach","volume":"259(11)","author":"Martinez-Martin","year":"2012","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10072-009-0101-3","article-title":"Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease","volume":"30(4)","author":"Cabrini","year":"2009","journal-title":"Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10899-005-5557-3","article-title":"Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS)","volume":"21(4)","author":"Pallanti","year":"2005","journal-title":"Journal of Gambling Studies"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0053|cit53","first-page":"76\u201384","article-title":"The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study","volume":"166(1)","author":"Kim","year":"2009","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0054|cit54","first-page":"59\u201367","article-title":"Reliability and validity of a scale to measure change in persons with compulsive buying","volume":"64(1)","author":"Monahan","year":"1996","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0055|cit55","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"National Institute of Mental Health (NIMH)","year":"1970"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","article-title":"The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score","volume":"26(5)","author":"Jenkinson","year":"1997","journal-title":"Age and Ageing"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0057|cit57","first-page":"805\u201314","article-title":"The PDQ-8: development and validation of a short-form Parkinson's disease questionnaire","volume":"12(6)","author":"Jenkinson","year":"1997","journal-title":"Psychology & Health"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17(1)","author":"Yesavage","year":"1982","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"382\u20139","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44(12)","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0062|cit62","volume-title":"STAI Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1970"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-1781(91)90040-V","article-title":"Reliability and validity of the apathy evaluation scale","volume":"38(2)","author":"Marin","year":"1991","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0064|cit64","first-page":"99\u2013103","article-title":"A scale for the assessment of hedonic tone: the Snaith-Hamilton Pleasure Scale","volume":"167(1)","author":"Snaith","year":"1995","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0065|cit65","first-page":"768\u201374","article-title":"Factor structure of the Barratt impulsiveness scale","volume":"51(6)","author":"Patton","year":"1995","journal-title":"Journal of Clinical Psychology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0066|cit66","first-page":"2129\u201370","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23(15)","author":"Goetz","year":"2008","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"16","key":"10.1002\/14651858.CD015046.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"2398\u20132403","DOI":"10.1002\/mds.22341","article-title":"The unified dyskinesia rating scale: presentation and clinimetric profile","volume":"23","author":"Goetz","year":"2008","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"4","key":"10.1002\/14651858.CD015046.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"390\u20134","DOI":"10.1002\/mds.870090403","article-title":"Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment","volume":"9","author":"Goetz","year":"1994","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/mds.22110","article-title":"SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson\u2019s disease","volume":"23(12)","author":"Martinez-Martin","year":"2008","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0070|cit70","first-page":"540\u20135","article-title":"A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale","volume":"14(6)","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/mds.21740","article-title":"The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument","volume":"22(16)","author":"Stiasny-Kolster","year":"2007","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0072|cit72","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies [last updated March 2025]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5.1. Cochrane, 2025 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0073|cit73","first-page":"l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical Research Edition)"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0074|cit74","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0075|cit75","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2025"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0076|cit76","unstructured":"Boutron I Page MJ Higgins JP Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0077|cit77","unstructured":"Higgins JP Eldridge S Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0078|cit78","unstructured":"Deeks JJ Higgins JP Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0079|cit79","unstructured":"Higgins JP Li T Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0080|cit80","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0081|cit81","first-page":"l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ (Clinical Research Edition)"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1539\u201358","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0083|cit83","first-page":"383\u201394","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64(4)","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1007\/s00415-023-11814-y","article-title":"Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson\u2019s disease: a multicenter, parallel, randomised,double-blind, Phase 2b Clinical trial","volume":"270(10)","author":"Laurencin","year":"2023","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0085|cit85","unstructured":"Study of clonidine efficacy for the treatment of impulse control disorders in Parkinson's disease https:\/\/clinicaltrials.gov\/study\/NCT03552068"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"792\u20139","DOI":"10.1212\/WNL.0b013e3182840678","article-title":"Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers","volume":"80(9)","author":"Okai","year":"2013","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD015046.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/mds.26108","article-title":"Predictors of response to a cognitive behavioral intervention for impulse control behaviors in Parkinson's disease","volume":"30","author":"Okai","year":"2015","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0088|cit88","doi-asserted-by":"crossref","unstructured":"A nurse-led intervention to reduce dopamine dysregulation syndrome in Parkinson's disease patients and their carers ISRCTN Registry; https:\/\/www.isrctn.com\/ISRCTN82636004 https:\/\/doi.org\/10.1186\/ISRCTN82636004","DOI":"10.1186\/ISRCTN82636004"},{"issue":"9","key":"10.1002\/14651858.CD015046.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1212\/WNL.0000000000000729","article-title":"Naltrexone for impulse control disorders in Parkinson disease -- a placebo-controlled study","volume":"83","author":"Papay","year":"2014","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0090|cit90","unstructured":"Naltrexone for impulse control disorders in Parkinson's disease https:\/\/clinicaltrials.gov\/study\/NCT01052831"},{"issue":"3","key":"10.1002\/14651858.CD015046.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"400\u20134","DOI":"10.1002\/ana.22029","article-title":"Pathological gambling in Parkinson disease is reduced by amantadine","volume":"68","author":"Thomas","year":"2010","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0092|cit92","unstructured":"Anheim M Randomized placebo controlled trial evaluating the efficacy of pimavanserin, a selective serotonin 5-hydroxytryptamine-2A (5HT2A) inverse agonist, to treat impulse control disorders in parkinson's disease. (PIMPARK) ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0093|cit93","unstructured":"Cherkasova MV Rtms over the dorsolateral prefrontal cortex for the treatment of impulse control disorders in parkinson's disease ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0094|cit94","unstructured":"Koh J Mindfulness meditation for impulsive-compulsive behaviors in Parkinson's disease: a randomized-controlled study UMIN CTR"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0095|cit95","doi-asserted-by":"crossref","unstructured":"Mehrotra B Rai N Mr R Budhakar A Aggarwal R Agarbattiwala RV Impact of dance or music and meditation on the progression of parkinson disease with mild or moderate severity: protocol for a pilot randomized controlled trial JMIR Research Protocols 2024 10.2196\/59018","DOI":"10.2196\/preprints.59018"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0096|cit96","unstructured":"Paschen S Bilateral subthalamic stimulation in PD patients with impulse control disorders - stimpulsecontrol ClinicalTrials.gov"},{"issue":"2","key":"10.1002\/14651858.CD015046.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"235\u201348","DOI":"10.1002\/mds.29700","article-title":"Management of impulse control and related disorders in Parkinson's disease: an expert consensus","volume":"39","author":"Debove","year":"2024","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD015046.pub2-BIB0098|cit98","unstructured":"Witt K Levin J Van Eimeren T Hasan A Ebersbach G; German Parkinson\u2019s Guideline Group Diagnostics and treatment of impulse control disorders, psychosis and delirium: systemic review-based recommendations - guideline \"Parkinson's disease\" of the German Society of Neurology Journal of Neurology 10.1007\/s00415-024-12576-x"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:17:49Z","timestamp":1790579869000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015046.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":98,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015046.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]}}}